Vijay Bhaskar Gayam, MD
Gastroenterology · Rogers, ARNPI 1316296668
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (59.5%), travel and lodging and grants — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Boston Scientific at 45.0% of the total. Reporting peaked in 2024 at $5,042 and has fallen 55.1% since, to $2,262 in 2025.
Across 121 payments — averaging $95.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$5K
- AbbVie$2K
- Gilead$1K
- Cook Incorporated$1K
- Wilson Cook Medical Incorporated$533
- Johnson & Johnson$428
- plus $1K from 13 others
What the payments were for
- Grants$1,0009%
- Travel & lodging$3,64832%
- Food & beverage$6,86159%
- Education$290%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 42 | $5,191 |
| AbbVie | 22 | $1,801 |
| Gilead | 26 | $1,414 |
| Cook Incorporated | 1 | $1,000 |
| Wilson Cook Medical Incorporated | 3 | $533 |
| Johnson & Johnson | 4 | $428 |
| Cook Medical LLC | 4 | $420 |
| Fujifilm Healthcare Americas Corporation | 2 | $160 |
| Daiichi Sankyo Inc. | 2 | $153 |
| E.r. Squibb & Sons, L.L.C. | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $121 |
| Boehringer Ingelheim | 2 | $55 |
| Celltrion USA Inc. | 1 | $29 |
| ERBE USA Inc | 1 | $25 |
| Medtronic | 1 | $24 |
| Capsovision, Inc. | 1 | $22 |
| Olympus America Inc. | 1 | $16 |
| Avanos Medical | 1 | $13 |
| Micro-tech Endoscopy USA, Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OverStitch Endoscopic Suturing System$1,556
- AXIOS$1,285
- FUSION$935
- EXALT Model D$932
- Epclusa$723
- Skyrizi$399
- Mavyret$365
- Rinvoq$303
- STELARA$282
- GENERAL - THERAPIES$261
- Tremfya$256
- Vemlidy$239
- Resolution 360 Clip$145
- ZEPOSIA$125
- VIBERZI$125
- Creon$125
- INJECTAFER$125
How this compares
$11,538 in reported general payments places this provider in the 80th percentile of 108 gastroenterology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 11 | $74 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Rogers
- Christopher MillerRogers$7K
- Robert WellsRogers$6K
- Willliam WigingtonRogers$6K
- Glenn DavisLittle Rock$2.7M
- Ranga BalasekaranSpringdale$235K
- Ali KhanLittle Rock$49K
- Jaymie PenningtonLittle Rock$17K
- Michael JohnsonLittle Rock$17K
- David BackstedtLittle Rock$16K
- Hrair SimonianFort Smith$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.